主页 > 医药科学 >
【drug-news】乳腺癌患者抗议FDA取消Avastin的乳腺癌
http://www.usatoday.com/yourlife/health/medical/2011-01-05-avastin05_ST_N.htm
By Rita Rubin, USA TODAY
Christie Bowen awoke early one morning and couldn't figure out how to walk or get dressed.
She began having seizures as her husband helped her downstairs so they could drive to a hospital near their Windsor, Vt., home. Doctors there told her husband the breast cancer she had been diagnosed with three years earlier might have spread to her brain. She went by ambulance to Dartmouth-Hitchcock Medical Center, a half-hour away in Lebanon, N.H., where a neurologist quickly diagnosed her.
Cancer hadn't spread to her brain, nor had she suffered a stroke, another possibility. But she did have a rare, serious neurological condition linked to the anti-cancer drug Avastin.
... Avastin乳腺癌适应症被撤销_FDA_国际药业_健康网-医药产业作者:lizz 国际药业来源:本站原创 点击数: 健康网讯: FDA肿瘤药物顾问团拒绝批准罗氏的重要的肿瘤药物阿瓦斯汀的HER2阴性乳腺癌适应症,罗氏公司的股价受到影响开始下跌. ...www.healthoo.com/...400061.asp-2010-07-29-快照-Avastin乳腺癌适应症被撤销_FDA_国际药业_健康网-医药产业" FDA委员会拒绝基因泰克的Avastin新增乳腺癌适应症 - 生物医药...相信Avastin对乳腺癌患者是有益的.实际上,有不少医生已经为乳腺癌患者开Avastin的处... 在美国,医生可以为患者开FDA没有批准的适应症的处方(off-label use),但是制药公司不能...www.bioon.com/.../317281.shtml-2008-01-10-快照-FDA委员会拒绝基因泰克的Avastin新增乳腺癌适应症 - 生物医药..." 美国FDA质疑:Avastin治晚期乳腺癌并无优势-搜狐健康2010年7月23日... “Avastin的乳腺癌适应症可能会被撤销”,其他的分析师也认为FDA顾问小组将... 无恶化存活期是患者癌症没有恶化的时间阶段.在初期研究中Avastin静脉给药5....health.sohu.com/...20323.shtml-2010-07-23-快照-FDA质疑:Avastin治晚期乳腺癌并无优势-搜狐健康"[标签:content2]
阅读本文的人还阅读：
作者:admin@医学,生命科学 2011-01-06 11:02
医学,生命科学网